Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 39, n° 3
pages 464-475 (septembre 1998)
Doi : 10.1016/S0190-9622(98)70325-1
Cyclosporine consensus conference: With emphasis on the treatment of psoriasis

Mark Lebwohl, MDa, Charles Ellis, MDb, Alice Gottlieb, MD, PhDc, John Koo, MDd, Gerald Krueger, MDe, Kenneth Linden, MDg, Jerome Shupack, MDf, Gerald Weinstein, MDg
New York, New York; Ann Arbor, Michigan; Newark, New Jersey; San Francisco and Irvine, California; and Salt Lake City, Utah 
From the Departments of Dermatology at the Mount Sinai School of Medicine, New York a; University of Michigan Medical Center, Ann Arbor b;UMDNJ-Robert Wood Johnson Medical School, Newark c;University of California San Francisco,d; University of Utah School of Medicine, Salt Lake City e; New York University Medical Centerf; and University of California at Irvine College of Medicine.g 


Cyclosporine has been in worldwide use for 15 years for patients who have undergone transplantation operations and is now being used to control inflammatory reactions in other organs (eg, joints, bowel, and skin). Neoral, a more consistently absorbed form of cyclosporine, has recently been approved by the Food and Drug Administration for the treatment of psoriasis. This report outlines the indications, contraindications, dosage recommendations, monitoring requirements, adverse events, drug interactions, interactions with other psoriasis treatments, and suggestions for cyclosporine’s use in rotational therapy. (J Am Acad Dermatol 1998;39:464-75.)

The full text of this article is available in PDF format.

 Supported by a grant from Novartis Pharmaceuticals, Inc.
 Reprint requests: Mark Lebwohl, MD, Mt. Sinai Medical Center, Department of Dermatology, 5E 98th St, New York, NY 10029-6574.
 0190-9622/98/$5.00 + 0  16/1/92424

© 1998  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@